Matches in DBpedia 2014 for { <http://dbpedia.org/resource/SB-408,124> ?p ?o. }
Showing items 1 to 34 of
34
with 100 items per page.
- SB-408,124 abstract "SB-408,124 is a drug which is a non-peptide antagonist selective for the orexin receptor subtype OX1, with around 70x selectivity for OX1 over OX2 receptors, and improved oral bioavailability compared to the older OX1 antagonist SB-334,867. It is used in scientific research into the function of orexinergic neurons in the body.".
- SB-408,124 casNumber "288150-92-5".
- SB-408,124 iupacName "N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N'-[4-(dimethylamino)phenyl]urea".
- SB-408,124 thumbnail SB408124_structure.png?width=300.
- SB-408,124 wikiPageID "22230911".
- SB-408,124 wikiPageRevisionID "600800785".
- SB-408,124 c "19".
- SB-408,124 casNumber "288150".
- SB-408,124 f "2".
- SB-408,124 h "18".
- SB-408,124 hasPhotoCollection SB-408,124.
- SB-408,124 iupacName "N--N'-[4-phenyl]urea".
- SB-408,124 molecularWeight "356.368".
- SB-408,124 n "4".
- SB-408,124 o "1".
- SB-408,124 smiles "c3ccccc3NCNc1ccnc2c1cccc2F".
- SB-408,124 verifiedrevid "399128731".
- SB-408,124 width "240".
- SB-408,124 subject Category:Orexin_antagonists.
- SB-408,124 subject Category:Organofluorides.
- SB-408,124 subject Category:Quinolines.
- SB-408,124 subject Category:Sedatives.
- SB-408,124 subject Category:Ureas.
- SB-408,124 type Drug.
- SB-408,124 type DrugProduct.
- SB-408,124 type FunctionalSubstance.
- SB-408,124 comment "SB-408,124 is a drug which is a non-peptide antagonist selective for the orexin receptor subtype OX1, with around 70x selectivity for OX1 over OX2 receptors, and improved oral bioavailability compared to the older OX1 antagonist SB-334,867. It is used in scientific research into the function of orexinergic neurons in the body.".
- SB-408,124 label "SB-408,124".
- SB-408,124 sameAs m.05q7qhr.
- SB-408,124 sameAs Q7388912.
- SB-408,124 sameAs Q7388912.
- SB-408,124 wasDerivedFrom SB-408,124?oldid=600800785.
- SB-408,124 depiction SB408124_structure.png.
- SB-408,124 isPrimaryTopicOf SB-408,124.